<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>NEW SITE FOR SCHERING-PLOUGH</title>
    <meta content="MB232144" name="slug"/>
    <meta content="30" name="publication_day_of_month"/>
    <meta content="7" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Sunday" name="publication_day_of_week"/>
    <meta content="New Jersey Weekly Desk" name="dsk"/>
    <meta content="9" name="print_page_number"/>
    <meta content="14NJ" name="print_section"/>
    <meta content="1" name="print_column"/>
    <meta content="New York and Region" name="online_sections"/>
    <docdata>
      <doc-id id-string="1218750"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <series series.name="BRIEFING: PHARMACEUTICALS"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="indexing_service" type="descriptor">Mergers, Acquisitions and Divestitures</classifier>
        <classifier class="indexing_service" type="descriptor">Office Buildings and Other Commercial Properties</classifier>
        <location class="indexing_service">Summit (NJ)</location>
        <org class="indexing_service">Schering-Plough Corp</org>
        <org class="indexing_service">Novartis Ag</org>
        <person class="indexing_service">Demasters, Karen</person>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/New York and Region</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/New York and Region/New Jersey</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Classifieds/Job Market/Job Categories/Pharmaceutical, Biotechnology and Science</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Features/Travel/Guides/Destinations/North America</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Features/Travel/Guides/Destinations/North America/United States</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Features/Travel/Guides/Destinations/North America/United States/New Jersey</classifier>
        <classifier class="online_producer" type="general_descriptor">Mergers, Acquisitions and Divestitures</classifier>
        <classifier class="online_producer" type="general_descriptor">Office Buildings and Commercial Properties</classifier>
        <classifier class="online_producer" type="general_descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="online_producer" type="general_descriptor">Finances</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicine and Health</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20000730T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9E04E4D9173DF933A05754C0A9669C8B63" item-length="210" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>NEW SITE FOR SCHERING-PLOUGH</hl1>
      </hedline>
      <byline class="print_byline">By Karen Demasters</byline>
      <byline class="normalized_byline">Demasters, Karen</byline>
      <abstract>
        <p>Schering-Plough Corp plans to purchase 88-acre campus in Summit, NJ, from Novartis Pharmaceuticals Corp in order to expand its pharmaceutical research operations (S)</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>Schering-Plough Corporation, based in Madison, will purchase the Summit site now owned by Novartis Pharmaceuticals Corporation, which includes two million square feet of research and development, laboratory and office space.</p>
        <p>The 88-acre campus on Morris Avenue in Summit will be used to expand Schering-Plough's pharmaceutical research operations, according to Raul E. Cesan, Schering-Plough president.</p>
      </block>
      <block class="full_text">
        <p>Schering-Plough Corporation, based in Madison, will purchase the Summit site now owned by Novartis Pharmaceuticals Corporation, which includes two million square feet of research and development, laboratory and office space.</p>
        <p>The 88-acre campus on Morris Avenue in Summit will be used to expand Schering-Plough's pharmaceutical research operations, according to Raul E. Cesan, Schering-Plough president.</p>
        <p>Research scientists and support personnel from Schering-Plough's sites in Kenilworth, Union and Lafayette will relocate to Summit once the move is completed in mid-2003. The property will not change hands until the end of March 2003; until then Novartis will lease the space.</p>
        <p>Novartis, created in 1997 with the merger of Ciba-Geigy Corporation and Sandoz Corporation, will move its research and development operations from Summit to East Hanover, where its New Jersey operations are being consolidated, according to Paulo Costa, Novartis president.</p>
        <p>The East Hanover site will be expanded with $100 million in construction to include a 500,000-square-foot research building and an office building. Neither company would reveal the price for the Summit purchase, but the property and buildings are assessed at $202 million.</p>
        <p>Karen Demasters</p>
        <p>BRIEFING: PHARMACEUTICALS</p>
      </block>
    </body.content>
  </body>
</nitf>
